Search

Po-chih Chen

Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1621, 1626
Total Applications
947
Issued Applications
619
Pending Applications
116
Abandoned Applications
237

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16839403 [patent_doc_number] => 20210147415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION [patent_app_type] => utility [patent_app_number] => 17/091247 [patent_app_country] => US [patent_app_date] => 2020-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13241 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091247 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/091247
INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION Nov 5, 2020 Abandoned
Array ( [id] => 19674480 [patent_doc_number] => 12186318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-07 [patent_title] => Pharmaceutical composition for preventing or treating cancer comprising KSP inhibitor and mitosis inhibitor [patent_app_type] => utility [patent_app_number] => 17/083895 [patent_app_country] => US [patent_app_date] => 2020-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 38 [patent_no_of_words] => 12262 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/083895
Pharmaceutical composition for preventing or treating cancer comprising KSP inhibitor and mitosis inhibitor Oct 28, 2020 Issued
Array ( [id] => 16688291 [patent_doc_number] => 20210070767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/082650 [patent_app_country] => US [patent_app_date] => 2020-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30681 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082650 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/082650
Apelin receptor (APJ) agonists and uses thereof Oct 27, 2020 Issued
Array ( [id] => 16791608 [patent_doc_number] => 20210121425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/080523 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17456 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080523 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/080523
ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS Oct 25, 2020 Abandoned
Array ( [id] => 16776480 [patent_doc_number] => 20210113557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => METHODS OF TREATING PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 17/075808 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/075808
METHODS OF TREATING PROSTATE CANCER Oct 20, 2020 Abandoned
Array ( [id] => 16711822 [patent_doc_number] => 20210078969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => Nrf2 Activating Compounds and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/075152 [patent_app_country] => US [patent_app_date] => 2020-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075152 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/075152
Nrf2 activating compounds and uses thereof Oct 19, 2020 Issued
Array ( [id] => 17875460 [patent_doc_number] => 11447461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Benzothiophene-based selective estrogen receptor downregulators [patent_app_type] => utility [patent_app_number] => 17/074550 [patent_app_country] => US [patent_app_date] => 2020-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 25316 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074550 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/074550
Benzothiophene-based selective estrogen receptor downregulators Oct 18, 2020 Issued
Array ( [id] => 19777390 [patent_doc_number] => 12226410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6 [patent_app_type] => utility [patent_app_number] => 17/073603 [patent_app_country] => US [patent_app_date] => 2020-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 123 [patent_no_of_words] => 22575 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073603 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/073603
Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6 Oct 18, 2020 Issued
Array ( [id] => 16807794 [patent_doc_number] => 20210130347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES [patent_app_type] => utility [patent_app_number] => 17/071056 [patent_app_country] => US [patent_app_date] => 2020-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24527 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071056 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/071056
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases Oct 14, 2020 Issued
Array ( [id] => 16976116 [patent_doc_number] => 20210220353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => USE OF FAVIPIRAVIR IN TREATMENT OF CORONAVIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/070620 [patent_app_country] => US [patent_app_date] => 2020-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5340 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070620 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/070620
USE OF FAVIPIRAVIR IN TREATMENT OF CORONAVIRUS INFECTION Oct 13, 2020 Abandoned
Array ( [id] => 16765771 [patent_doc_number] => 20210111353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME [patent_app_type] => utility [patent_app_number] => 17/065816 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23436 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 345 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065816 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/065816
Compound and photoelectric device, image sensor, and electronic device including the same Oct 7, 2020 Issued
Array ( [id] => 16596583 [patent_doc_number] => 20210023114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN INFECTION [patent_app_type] => utility [patent_app_number] => 17/064267 [patent_app_country] => US [patent_app_date] => 2020-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064267 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/064267
Compositions and methods for treating an infection Oct 5, 2020 Issued
Array ( [id] => 17111692 [patent_doc_number] => 20210292289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => HETEROCYCLIC GLUTAMINASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/063066 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063066
HETEROCYCLIC GLUTAMINASE INHIBITORS Oct 4, 2020 Abandoned
Array ( [id] => 17913184 [patent_doc_number] => 20220315579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => PYRIDONE COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/033475 [patent_app_country] => US [patent_app_date] => 2020-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033475 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/033475
Pyridone compounds and methods of use Sep 24, 2020 Issued
Array ( [id] => 16748771 [patent_doc_number] => 20210100780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => METHODS FOR TREATING WILD TYPE ISOCITRATE DEHYDROGENASE 1 CANCERS [patent_app_type] => utility [patent_app_number] => 17/030844 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030844 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/030844
Methods for treating wild type isocitrate dehydrogenase 1 cancers Sep 23, 2020 Issued
Array ( [id] => 18018964 [patent_doc_number] => 20220370463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION [patent_app_type] => utility [patent_app_number] => 17/761027 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761027 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761027
STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION Sep 17, 2020 Pending
Array ( [id] => 17913183 [patent_doc_number] => 20220315578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/020114 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88966 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/020114
BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE Sep 13, 2020 Pending
Array ( [id] => 18567008 [patent_doc_number] => 20230257337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHOD FOR PRODUCING POLYGYLCEROL ESTERS OF POLYCARBOXYLIC ACIDS ESTERIFIED WITH OXOBUTANOL [patent_app_type] => utility [patent_app_number] => 18/004753 [patent_app_country] => US [patent_app_date] => 2020-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004753 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004753
METHOD FOR PRODUCING POLYGYLCEROL ESTERS OF POLYCARBOXYLIC ACIDS ESTERIFIED WITH OXOBUTANOL Sep 6, 2020 Pending
Array ( [id] => 17896992 [patent_doc_number] => 20220306654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => MECHANOREDOX REACTION USING PIEZOELECTRIC MATERIAL, AND PRODUCTION METHOD USING SAID REACTION [patent_app_type] => utility [patent_app_number] => 17/640135 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640135 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/640135
MECHANOREDOX REACTION USING PIEZOELECTRIC MATERIAL, AND PRODUCTION METHOD USING SAID REACTION Sep 3, 2020 Abandoned
Array ( [id] => 16613603 [patent_doc_number] => 20210032256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives [patent_app_type] => utility [patent_app_number] => 17/010089 [patent_app_country] => US [patent_app_date] => 2020-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 1064 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010089 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/010089
3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Sep 1, 2020 Abandoned
Menu